Neck Mass Found in 45-Year-Old Man

Poll

A 45-year-old man presents with a mass in the right neck. After the biopsy is performed, what is your diagnosis?

A 45-year-old man presents with a mass in the right neck. According to the pathology slide below, what is your diagnosis?

What is your diagnosis?

A. Leiomyosarcoma
B. Desmoid tumor
C. Spindle cell lipoma
D. Squamous cell carcinoma
Related Videos
head and neck cancer
head and neck cancer
head and neck cancer
head and neck cancer
head and neck cancer
Related Content
After observing a prevalence of thyroid cancer among transgender female patients through clinical observation, a study was prompted by clinicians in order to determine if this is an issue in a larger population.

Thyroid Cancer Rates Are Higher Among Transgender Female Veterans

October 29th 2023
Article

Study shows a high prevalence of thyroid cancer in transgender female patients.

David Sher on the Updated ASTRO Guidelines for Oropharyngeal Cancer

David Sher on the Updated ASTRO Guidelines for Oropharyngeal Cancer

September 15th 2017
Podcast

In this interview we discuss new clinical guidelines from ASTRO on the use of radiotherapy in treating oropharyngeal cancer.

Findings from a phase 2 trial also show that there is no progression-free survival or overall survival benefit with lapatinib plus chemoradiotherapy in patients with non-human papillomavirus–related head and neck cancer.

Lapatinib Does Not Improve CRT Outcomes in Non-HPV Head and Neck Carcinoma

October 27th 2023
Article

Findings from a phase 2 trial also show that there is no progression-free survival or overall survival benefit with lapatinib plus chemoradiotherapy in patients with non-human papillomavirus–related head and neck cancer.

A yoga intervention program in patients with head and neck cancer appears to correlate with significantly fewer feeding tube placements compared with those receiving usual care.

Yoga May Reduce Physical Decline in HNC Population Receiving Radiotherapy

October 24th 2023
Article

A yoga intervention program in patients with head and neck cancer appears to correlate with significantly fewer feeding tube placements compared with those receiving usual care.

Sacituzumab Govitecan Displays Antitumor Activity in Advanced HNSCC

Sacituzumab Govitecan Displays Antitumor Activity in Advanced HNSCC

October 21st 2023
Article

Sacituzumab govitecan showed anti-tumor activity in patients with pretreated metastatic or locally recurrent head and neck squamous cell carcinoma.

Investigators will assess the safety and pharmacodynamics of ALE.C04 in patients with CLDN1-positive head and neck squamous cell carcinoma as part of a phase 1/2 clinical trial.

FDA Grants Fast Track Designation to ALE.C04 in CLDN1+ HNSCC

August 24th 2023
Article

Investigators will assess the safety and pharmacodynamics of ALE.C04 in patients with CLDN1-positive head and neck squamous cell carcinoma as part of a phase 1/2 clinical trial.